This proposal seeks support to develop and study an educational video game for children with diabetes. Diabetes is managed largely by patients themselves; patient knowledge and attitude are critical to the success of treatment. Phase I established the feasibility of using a computer game to teach children about diabetes. Concurrently, a prototype game was designed for a popular home-based video game system. Phase II will expand this prototype into a commercial quality educational video game and study its efficacy in diabetes education in a controlled trial. Children with diabetes, age 10 to 14, will receive the video game to use at home for two months. Researchers will measure subject's knowledge of diabetes, attitudes, self-efficacy, behavior and metabolic control using pre-tests, post-tests and a six-month follow-up. The results will be compared with patients not receiving the intervention. As a check on the measures, the game cartridges will unobtrusively measure usage and the players' ability to master the diabetes-based game strategy. The researchers hypothesize that a properly designed educational intervention, when combined with intrinsic motivations of entertainment quality video games, could lead to significant improvements in the knowledge, attitudes, self-efficacy, behavior and metabolic control of children with diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44DK044402-03
Application #
2143778
Study Section
Special Emphasis Panel (ZRG1-HUD-3 (04))
Project Start
1992-09-30
Project End
1994-09-29
Budget Start
1993-09-30
Budget End
1994-09-29
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Health Hero Network, Inc.
Department
Type
DUNS #
City
Mountain View
State
CA
Country
United States
Zip Code
94040
Brown, S J; Lieberman, D A; Germeny, B A et al. (1997) Educational video game for juvenile diabetes: results of a controlled trial. Med Inform (Lond) 22:77-89